2025 Partners
MilliporeSigma
Program Partner
MilliporeSigma is a leading Life Science company, providing solutions as a strategic partner to
help advance the promise of life-saving therapies. Our integrated CTDMO Services combine our
expertise in contract development, manufacturing, and testing from pre-clinical to commercial
to accelerate your milestones and breakthrough – with one experienced partner. We offer 15+
years of leading expertise in the conjugation of drug linkers to monoclonal antibodies (mAbs) and
facilities specialized for handling highly potent compounds. To fit your ADC manufacturing needs,
our joint ADC offering includes a comprehensive processing portfolio from cell culture media to
buffers, salts, and stabilizers and from chromatography to TFF equipment, including single-use
templates.
Curia Global
Expertise Partner
Curia is a global Contract Development and Manufacturing Organization with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing to make treatments broadly accessible to patients. Our Small Molecules offering spans discovery to commercial manufacturing and fill-finish services, integrating scientific, process, regulatory and analytical capabilities. Curia’s scalable technologies and dedicated teams advance your program through drug substance and drug product manufacturing. From curiosity to cure, we are your trusted ally to accelerate life-changing therapeutics.
GBI Bio
Innovation Partner
GBI Bio's mission is to eliminate the manufacturing risk for companies developing complex biologic therapeutics by being the pre-eminent provider of high-quality, cost-effective, flexible and timely cGMP compliant manufacturing solutions, from pre-clinical development through commercial product supply. By integrating our services in one location, Goodwin provides a Single Source Solution™ to anticipate and overcome the challenges you face with your biopharmaceutical candidate, whether it be complex proteins such as monoclonal antibodies or a sophisticated Antibody Drug Conjugate (ADC).
Intertek
Exhibition Partner
With nearly three decades of experience in large molecule bioanalysis and characterization, our experts have considerable knowledge of the evolving regulatory framework across various regions and the scientific background of this product class. By bringing quality and safety to life, our scientists work with clients globally, helping them meet all regulatory expectations and specifications for successful drug substance and drug product release. For ADCs, we provide expertise in GLP/GMP laboratory testing, bioanalysis, characterization, purity and impurity profile, stability testing and comparability, and more – all delivered consistently with precision, pace, and passion, allowing you to power ahead safely.
Vector Laboratories
Exhibition Partner
Vector Laboratories is a trusted critical component manufacturer, working with biopharma companies to employ BioDesign™, a consultation service consolidating chemical synthesis mastery, bioconjugation expertise, and a deep knowledge of how linkers impact ADC performance. Combining the long-established credibility of Vector Laboratories with new proprietary capabilities and technologies gained through the acquisition of Quanta BioDesign, our collaborative approach and dPEG® linker platform provide allow the ultimate flexibility in ADC conjugation, supplying both off-the-shelf and custom linker options.
SynOligo
Exhibition Partner
Headquartered in Morrisville, NC, USA, Synoligo Biotechnologies is a Contract Research and Development Organization (CRDO) specialized in manufacturing complex and highly modified oligonucleotide for academic, biotech start-up and large pharmaceutical communities. Synoligo is a leading oligonucleotide manufacturing company providing high quality, cost-effective custom oligonucleotides at varying scales for research, diagnostic, and therapeutic applications.
Nona Biosciences
Exhibition Partner
Nona Biosciences is a Boston-based Biotech company specialized in fully human therapeutic antibody technology. Our proprietary Harbour Mice® technology are fully human transgenic mice platforms for either conventional fully human antibody (H2L2) or heavy chain only (HCAb) antibody discovery, engineering, and development. The HCAb platform is fully optimized and clinically validated with global patented protection.
BSP Pharmaceuticals
Exhibition Partner
BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxic characteristics for the pharmaceuticals industry. BSP has been at the forefront in the fight against cancer since 2006. Innovation is the hallmark of BSP with investments in new technologies and production methods in a high containment plant.